ResMed | Des Atouts



Assets Changement Date
Ansell USD 3.24B 717.4M 2024-06
AtriCure USD 609.33M 5.74M 2024-12
Baxter International USD 25.78B 894M 2024-12
Cochlear AUD 2.75B 214.6M 2024-06
Cooper Companies USD 12.22B 93M 2025-01
CSL USD 38.02B 718M 2024-06
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Fisher Paykel Healthcare NZD 2.44B 153.7M 2024-09
Globus Medical USD 5.25B 165.71M 2024-12
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Idexx Laboratories USD 3.29B 57.32M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Philips EUR 28.98B 498M 2024-12
Ramsay Health Care AUD 20.66B 237M 2024-12
ResMed USD 7.14B 81.08M 2024-12
Sigma Healthcare AUD 1.7B 324.84M 2024-07
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Steris USD 10.01B 233.78M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12



ResMed Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.